S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   168.45 (-2.46%)
MSFT   415.73 (+0.51%)
META   501.93 (+0.34%)
GOOGL   154.77 (-0.06%)
AMZN   183.81 (+0.10%)
TSLA   156.58 (-3.03%)
NVDA   867.80 (+0.91%)
AMD   162.80 (+1.55%)
NIO   3.81 (-2.06%)
BABA   69.39 (-1.74%)
T   16.05 (-1.17%)
F   12.09 (-1.14%)
MU   120.48 (-0.73%)
GE   154.85 (+0.75%)
CGC   6.98 (+0.00%)
DIS   114.01 (+0.94%)
AMC   2.68 (+8.50%)
PFE   25.83 (-0.31%)
PYPL   63.87 (+0.57%)
XOM   118.83 (-0.71%)

Alkermes (ALKS) Short Interest Ratio & Short Volume

$23.84
-0.18 (-0.75%)
(As of 12:09 PM ET)

Alkermes Short Interest Data

Current Short Volume
14,340,000 shares
Previous Short Volume
14,080,000 shares
Change Vs. Previous Month
+1.85%
Dollar Volume Sold Short
$388.18 million
Short Interest Ratio / Days to Cover
7.5
Last Record Date
March 31, 2024
Outstanding Shares
169,180,000 shares
Percentage of Shares Shorted
8.48%
Today's Trading Volume
398,872 shares
Average Trading Volume
1,891,181 shares
Today's Volume Vs. Average
21%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Alkermes ?

Sign up to receive the latest short interest report for Alkermes and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALKS Short Interest Over Time

ALKS Days to Cover Over Time

ALKS Percentage of Float Shorted Over Time

Alkermes Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202414,340,000 shares $388.18 million +1.9%N/A7.5 $27.07
3/15/202414,080,000 shares $404.80 million +8.1%N/A7.7 $28.75
2/29/202413,020,000 shares $386.56 million +6.6%N/A5.6 $29.69
2/15/202412,220,000 shares $397.88 million +4.8%N/A4.9 $32.56
1/31/202411,660,000 shares $315.40 million -11.9%N/A5 $27.05
1/15/202413,230,000 shares $373.09 million -5.6%N/A5 $28.20
12/31/202314,020,000 shares $388.91 million +44.8%N/A5.4 $27.74
12/15/20239,680,000 shares $265.43 million +24.4%N/A3.7 $27.42
11/30/20237,780,000 shares $187.81 million -2.3%N/A3.8 $24.14
11/15/20237,960,000 shares $188.73 million -0.4%N/A4.2 $23.71
10/31/20237,990,000 shares $193.28 million +9.9%N/A4.2 $24.19
10/15/20237,270,000 shares $201.60 million -16.8%N/A3.9 $27.73
9/30/20238,740,000 shares $244.81 million -10.0%N/A5.1 $28.01
9/15/20239,710,000 shares $287.42 million +2.4%N/A5.6 $29.60
8/31/20239,480,000 shares $276.72 million +16.0%N/A5.5 $29.19
8/15/20238,170,000 shares $235.79 million +33.7%N/A5.3 $28.86
7/31/20236,110,000 shares $178.90 million +1.0%N/A4.2 $29.28
7/15/20236,050,000 shares $184.16 million +3.6%N/A4.5 $30.44
6/30/20235,840,000 shares $182.79 million -8.9%N/A4.2 $31.30
6/15/20236,410,000 shares $204.67 million -10.1%N/A4.8 $31.93
5/31/20237,130,000 shares $206.27 million -4.4%N/A5.6 $28.93
5/15/20237,460,000 shares $231.26 million -1.8%N/A5.9 $31.00
4/30/20237,600,000 shares $216.98 million -13.9%N/A5.8 $28.55
4/15/20238,830,000 shares $259.16 million -5.3%N/A7.1 $29.35
3/31/20239,320,000 shares $262.73 million -1.6%N/A7.5 $28.19
3/15/20239,470,000 shares $252.09 million +5.5%N/A7.6 $26.62
2/28/20238,980,000 shares $240.13 million No ChangeN/A6.9 $26.74
2/15/20238,980,000 shares $242.37 million -1.8%N/A6.6 $26.99
1/31/20239,140,000 shares $261.77 million -2.4%N/A6.5 $28.64
1/15/20239,360,000 shares $255.62 million +1.9%N/A5.7 $27.31
12/30/20229,190,000 shares $240.13 million +3.6%N/A5.4 $26.13
12/15/20228,870,000 shares $222.55 million +1.4%N/A5.1 $25.09
11/30/20228,750,000 shares $216.83 million -4.0%N/A5.2 $24.78
11/15/20229,110,000 shares $205.70 million +2.7%N/A5.4 $22.58
10/31/20228,870,000 shares $201.35 million -2.4%N/A5.5 $22.70
10/15/20229,090,000 shares $205.62 million -0.8%N/A5.6 $22.62
9/30/20229,160,000 shares $204.54 million +4.9%N/A6.4 $22.33
9/15/20228,730,000 shares $207.51 million +5.1%N/A6.2 $23.77
8/31/20228,310,000 shares $196.70 million +8.2%N/A5.8 $23.67
8/15/20227,680,000 shares $204.29 million +0.5%N/A5.2 $26.60
Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

ALKS Short Interest - Frequently Asked Questions

What is Alkermes' current short interest?

Short interest is the volume of Alkermes shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 14,340,000 shares of ALKS short. Learn More on Alkermes' current short interest.

What is a good short interest ratio for Alkermes?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALKS shares currently have a short interest ratio of 8.0. Learn More on Alkermes's short interest ratio.

Which institutional investors are shorting Alkermes?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alkermes: Wolverine Trading LLC, Citadel Advisors LLC, Affinity Asset Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Alkermes' short interest increasing or decreasing?

Alkermes saw a increase in short interest in March. As of March 31st, there was short interest totaling 14,340,000 shares, an increase of 1.8% from the previous total of 14,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Alkermes' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Alkermes: Madrigal Pharmaceuticals, Inc. (16.88%), Amicus Therapeutics, Inc. (11.00%), Ionis Pharmaceuticals, Inc. (7.11%), Geron Co. (8.53%), Agios Pharmaceuticals, Inc. (12.06%), Dynavax Technologies Co. (13.73%), Ligand Pharmaceuticals Incorporated (4.05%), Pacira BioSciences, Inc. (8.04%), Ironwood Pharmaceuticals, Inc. (14.48%), MannKind Co. (13.21%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Alkermes stock?

Short selling ALKS is an investing strategy that aims to generate trading profit from Alkermes as its price is falling. ALKS shares are trading down $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Alkermes?

A short squeeze for Alkermes occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALKS, which in turn drives the price of the stock up even further.

How often is Alkermes' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALKS, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ALKS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners